SEC Form 4 · accession 0001213900-18-015548
ADIAL PHARMACEUTICALS, INC. · ADIL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William B. Stilley III
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Nov 12, 2018
Accepted (ET)
Nov 13, 2018 · 6:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513525
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to purchase unitsF1 | $5.00 | Nov 12, 2018 | J | 36,800 | D | Jul 31, 2018 | Jul 31, 2023 | Units | 73,600 | 0 | D |
| Warrant to purchase common stockF1 | $5.00 | Nov 12, 2018 | J | 36,800 | A | Nov 12, 2018 | Jul 31, 2023 | Common Stock | 36,800 | 36,800 | D |
| Warrant to purchase common stockF1 | $6.25 | Nov 12, 2018 | J | 36,800 | A | Nov 12, 2018 | Jul 31, 2023 | Common Stock | 36,800 | 36,800 | D |
Explanation of responses
- F1On November 12, 2018, Mr. Stilley exchanged a warrant to purchase 36,800 units, each unit consisting of a share of common stock and a warrant to purchase a share of common stock, for two separate warrants to purchase 36,800 shares of common stock.